Literature DB >> 30818169

POLE proofreading defects: Contributions to mutagenesis and cancer.

Vivian S Park1, Zachary F Pursell2.   

Abstract

DNA polymerases are uniquely poised to contribute to the elevated mutation burdens seen in many human tumors. These mutations can arise through a number of different polymerase-dependent mechanisms, including intrinsic errors made using template DNA and precursor dNTPs free from chemical modifications, misinsertion events opposite chemically damaged template DNA or insertion events using modified nucleotides. While specific DNA repair polymerases have been known to contribute to tumorigenesis, the role of replication polymerases in mutagenesis in human disease has come into sharp focus over the last decade. This review describes how mutations in these replication DNA polymerases help to drive mutagenesis and tumor development, with particular attention to DNA polymerase epsilon. Recent studies using cancer genome sequencing, mutational signature analyses, yeast and mouse models, and the influence of mismatch repair on tumors with DNA polymerase mutations are discussed.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA polymerase; Exonuclease proofreading; Mutagenesis; Tumorigenesis

Mesh:

Substances:

Year:  2019        PMID: 30818169      PMCID: PMC6467506          DOI: 10.1016/j.dnarep.2019.02.007

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  133 in total

1.  DNA polymerase epsilon catalytic domains are dispensable for DNA replication, DNA repair, and cell viability.

Authors:  T Kesti; K Flick; S Keränen; J E Syväoja; C Wittenberg
Journal:  Mol Cell       Date:  1999-05       Impact factor: 17.970

2.  Exonuclease proofreading by human mitochondrial DNA polymerase.

Authors:  A A Johnson; K A Johnson
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

3.  Defective DNA polymerase-delta proofreading causes cancer susceptibility in mice.

Authors:  R E Goldsby; N A Lawrence; L E Hays; E A Olmsted; X Chen; M Singh; B D Preston
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

Review 4.  DNA replication fidelity.

Authors:  T A Kunkel; K Bebenek
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

5.  Identification and cloning of two histone fold motif-containing subunits of HeLa DNA polymerase epsilon.

Authors:  Y Li; Z F Pursell; S Linn
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

6.  The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta.

Authors:  C Masutani; R Kusumoto; A Yamada; N Dohmae; M Yokoi; M Yuasa; M Araki; S Iwai; K Takio; F Hanaoka
Journal:  Nature       Date:  1999-06-17       Impact factor: 49.962

7.  Analysis of the essential functions of the C-terminal protein/protein interaction domain of Saccharomyces cerevisiae pol epsilon and its unexpected ability to support growth in the absence of the DNA polymerase domain.

Authors:  R Dua; D L Levy; J L Campbell
Journal:  J Biol Chem       Date:  1999-08-06       Impact factor: 5.157

8.  Spontaneous frameshift mutations in Saccharomyces cerevisiae: accumulation during DNA replication and removal by proofreading and mismatch repair activities.

Authors:  C N Greene; S Jinks-Robertson
Journal:  Genetics       Date:  2001-09       Impact factor: 4.562

9.  HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two novel histone-fold proteins.

Authors:  R A Poot; G Dellaire; B B Hülsmann; M A Grimaldi; D F Corona; P B Becker; W A Bickmore; P D Varga-Weisz
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

10.  The 3'-->5' exonucleases of DNA polymerases delta and epsilon and the 5'-->3' exonuclease Exo1 have major roles in postreplication mutation avoidance in Saccharomyces cerevisiae.

Authors:  H T Tran; D A Gordenin; M A Resnick
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

View more
  18 in total

1.  Kinetic investigation of the polymerase and exonuclease activities of human DNA polymerase ε holoenzyme.

Authors:  Walter J Zahurancik; Zucai Suo
Journal:  J Biol Chem       Date:  2020-10-13       Impact factor: 5.157

2.  Deleterious mutations in esophageal carcinoma cuniculatum detected by next generation sequencing.

Authors:  Feng Yin; Kai Wang; Ming Hu; Petr Starostik; Kimberly J Newsom; Xiuli Liu
Journal:  Int J Clin Exp Pathol       Date:  2022-01-15

3.  Mouse model and human patient data reveal critical roles for Pten and p53 in suppressing POLE mutant tumor development.

Authors:  Vivian S Park; Meijuan J S Sun; Wesley D Frey; Leonard G Williams; Karl P Hodel; Juliet D Strauss; Sydney J Wellens; James G Jackson; Zachary F Pursell
Journal:  NAR Cancer       Date:  2022-03-03

4.  Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.

Authors:  Marina Stasenko; Irina Tunnage; Charles W Ashley; Maria M Rubinstein; Alicia J Latham; Arnaud Da Cruz Paula; Jennifer J Mueller; Mario M Leitao; Claire F Friedman; Vicky Makker; Robert A Soslow; Deborah F DeLair; David M Hyman; Dimitriy Zamarin; Kaled M Alektiar; Carol A Aghajanian; Nadeem R Abu-Rustum; Britta Weigelt; Karen A Cadoo
Journal:  Gynecol Oncol       Date:  2019-11-19       Impact factor: 5.482

5.  Characteristics of Pan-Cancer Patients With Ultrahigh Tumor Mutation Burden.

Authors:  Hong Yuan; Jun Ji; Min Shi; Yan Shi; Jing Liu; Junwei Wu; Chen Yang; Wenqi Xi; Qingyuan Li; Wei Zhu; Jingjie Li; Xiaoli Gong; Jun Zhang
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

6.  POLE Mutation Spectra Are Shaped by the Mutant Allele Identity, Its Abundance, and Mismatch Repair Status.

Authors:  Karl P Hodel; Meijuan J S Sun; Nathan Ungerleider; Vivian S Park; Leonard G Williams; David L Bauer; Victoria E Immethun; Jieqiong Wang; Zucai Suo; Hua Lu; James B McLachlan; Zachary F Pursell
Journal:  Mol Cell       Date:  2020-06-03       Impact factor: 19.328

7.  Human genes differ by their UV sensitivity estimated through analysis of UV-induced silent mutations in melanoma.

Authors:  Ivan P Gorlov; Christopher I Amos; Spiridon Tsavachidis; Colin Begg; Eva Hernando; Chao Cheng; Ronglai Shen; Irene Orlow; Li Luo; Marc S Ernstoff; Joel Parker; Nancy E Thomas; Olga Y Gorlova; Marianne Berwick
Journal:  Hum Mutat       Date:  2020-07-15       Impact factor: 4.700

8.  POLE mutations improve the prognosis of endometrial cancer via regulating cellular metabolism through AMF/AMFR signal transduction.

Authors:  Yiran Li; Yiding Bian; Kai Wang; Xiao-Ping Wan
Journal:  BMC Med Genet       Date:  2019-12-21       Impact factor: 2.103

Review 9.  Acetylation and Deacetylation of DNA Repair Proteins in Cancers.

Authors:  Shiqin Li; Bingbing Shi; Xinli Liu; Han-Xiang An
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

10.  Ultra-mutated colorectal cancer patients with POLE driver mutations exhibit distinct clinical patterns.

Authors:  Hanguang Hu; Wen Cai; Dehao Wu; Wangxiong Hu; Li Dong Wang; Jianshan Mao; Shu Zheng; Weiting Ge
Journal:  Cancer Med       Date:  2020-10-30       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.